New incident report
Incident Report Number: 2018-0476
Registrant Reference Number: USA-BAYERBAH-2017-US0078889 (Report 465204)
Registrant Name (Full Legal Name no abbreviations): Bayer inc
Address: 2920 Matheson BLVD
City: Mississaugua
Prov / State: ON
Country: Canada
Postal Code: L5W5R6
Human
Country: UNITED STATES
Prov / State: CALIFORNIA
PMRA Registration No. PMRA Submission No. EPA Registration No. 11556-152
Product Name: Advantage II Large Cat
Other (specify)
SPOT ONNo
Unknown
Other
Sex: Male
Age: Unknown / Inconnu
System
Unknown / Inconnu
Yes
No
Non-occupational
Pesticide Spill
Unknown
Skin
<=15 min / <=15 min
<=30 min / <=30 min
on approximately September 22 2017, a man , administered an unknown pain medication since approximately 2017, was exposed to an unknown amount of advantageII large cat, when he spilled the product on a fifth digit knuckle, on the left hand; immediately post exposure, the individual experienced pain at the exposure site; the individual washed his hands with an unspecified soap for 10 minutes, then applied isopropyl alcohol. On an unspecified date post exposure, in approximately 2017, the individual played the guitar and piano, after a few minutes the clinical sign worsened. The individual was not examined by a physician and the clinical sign continued.
Major
O - Unclassifiable/unassessableDirect product exposure occurred. Affected area compatible with exposed area. Time to onset short. Pain at exposure site is not typically seen however may be related to product exposure. However recurrence of sign and ongoing pain at exposure site is not expected, in particular not as the product was removed from the exposure site. The persons underlying condition requiring ongoing application of unspecified pain medication may play a role in recurrence of signs. Further chronology is unclear as duration of sign not described. No medical exam performed and thus no further information available. Due to limited information, a product relation is unassessable. Preliminary assessment. Pending the final assessment after evaluation by medical doctor. If assessment is changed, the final statement will be submitted.